Clinical Trial Update: First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing first-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphomas with maintenance therapy; the study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Lymphoplasmacytic Lymphoma
• Marginal Zone Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Polish Lymphoma Research Group | Conditions: Follicular Lymphoma, Marginal Zone Lymphoma | Phase 3 | Status: COMPLETED